Investment Summary |
|
|---|---|
| Date | 2021-09-16 |
| Target | Amolyt Pharma |
| Sector | Life Science |
| Investor(s) |
Andera Partners
EQT Life Sciences |
| Deal Type | Venture |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 2001 |
| PE ASSETS | 3.7B EUR |
| Size | Large |
| Type | Sector Agnostic |
Andera Partners is a private investment firm focused on several strategies. The Firm invests in life science opportunities through its BioDiscovery group. The Firm invests in Western European small to mid-sized companies (€30 to €300 million of revenue) through its Winch Capital group. Andera invests in small to mid-sized French companies (€10 to €100 million of revenue) through its Cabestan Capital team. Andera invests in €5 to €45 million of mezzanine capital to support small to mid-sized French companies. Andera Partners was established in 2001 and is headquartered in Paris.
| DEAL STATS | # |
|---|---|
| Overall | 91 of 106 |
| Sector: Life Science M&A | 23 of 27 |
| Type: Venture M&A Deals | 24 of 28 |
| Country: France M&A | 60 of 70 |
| Year: 2021 M&A | 9 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-09 |
Evommune
Los Altos, California, United States Evommune is a biopharmaceutical company developing innovative therapies in the area of chronic inflammation, particularly in dermatological conditions. Evommune was founded in 2020 and is based in Los Altos, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-26 |
Exciva
Heidelberg, Germany Exciva is a clinical biotech company developing a novel therapeutic compound for the treatment of behavioral and psychological symptoms in alzheimer’s patients. Exciva was founded in 2016 and is based in Heidelberg, Germany. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| DEAL STATS | # |
|---|---|
| Overall | 41 of 47 |
| Sector: Life Science M&A | 25 of 30 |
| Type: Venture M&A Deals | 35 of 39 |
| Country: France M&A | 3 of 4 |
| Year: 2021 M&A | 9 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-09 |
Evommune
Los Altos, California, United States Evommune is a biopharmaceutical company developing innovative therapies in the area of chronic inflammation, particularly in dermatological conditions. Evommune was founded in 2020 and is based in Los Altos, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-22 |
Egle
Paris, France Egle is a biotechnology company focused on developing first in class T-regulatory cell therapies based on Treg-starvers for oncology and autoimmune diseases. Egle was founded in 2020 and is based in Paris, France. |
Buy | - |
